|
Module
3: Reducing Cardiovascular Risk
in Kidney Transplant Recipients
|
Certified
for 2 Category 1 AMA Credits
Sponsored by the University
of Alabama School of Medicine
Division of Continuing Medical Education
| Release Date:
September 24, 2007 |
Expiration
Date: July 31, 2010
|
| OBJECTIVES: |
|
After
reading this online course module, participants should
be able to:
- Assess the risk of posttransplant
cardiovascular disease in the transplant recipient.
- Recommend therapeutic interventions
to the transplant center to decrease the risk of cardiovascular
disease development.
- Identify goals for hypertension
and cholesterol levels.
- Develop recommendations for
patients to alter lifestyle to decrease the risk of cardiovascular
disease development.
- Recognize interactions of
commonly prescribed cardiovascular agents with immunosuppressive
medications.
|
| Top of Page |
| FACULTY: |
| Program
Chairs
Robert Gaston,
MD
University of Alabama at Birmingham School of Medicine
Birmingham, Alabama
Andrew D. Howard,
MD, FACP
Metropolitan Nephrology Associates
Alexandria, Virginia
Authors
Steve Katznelson,
MD
Keith Superdock, MD, FACP
Alan Wilkinson, MD, FRCP
Program
Faculty
Douglas Amare,
MD
Nephrology Associates
Mobile, Alabama
Mary T. Behrens,
MD, FACP
Mid-Atlantic Nephrology Associates, P.A.
Baltimore, Maryland
Mark Benfield,
MD
University of Alabama at Birmingham School of Medicine
Birmingham, Alabama
Margaret Johnson
Bia, MD
Yale University School of Medicine
New Haven, Connecticut
Daniel C. Brennan,
MD, FACP
Washington University School of Medicine
Barnes-Jewish Hospital
St. Louis, Missouri
Joseph Buell,
MD
University of Cincinnati College of Medicine
Cincinnati, Ohio
David C. Cronin
II, MD, PhD
Yale University School of Medicine
New Haven, Connecticut
Gabriel Danovitch,
MD
University of California, Los Angeles
David Geffen School of Medicine
Los Angeles, California
Stanley Jordan,
MD
Cedars-Sinai Health System
Los Angeles, California
Michelle Josephson,
MD
University of Chicago Pritzker School of Medicine
Chicago, Illinois
Steve Katznelson,
MD
California Pacific Medical Center
San Francisco, California
David Laskow,
MD
Robert Wood Johnson Medical Center
University of Medicine and Dentistry of New Jersey
New Jersey Medical School
Newark, New Jersey
Mariana Markell,
MD
SUNY Downstate Medical Center
Brooklyn, New York
Jerry McCauley,
MD, MPH
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania
Minnie Sarwal,
MD, PhD
Stanford University School of Medicine
Stanford, California
Hamid Shidban,
MD
St. Vincent Medical Center
Los Angeles, California
Wadi Suki, MD,
FACP
The Methodist Hospital
Baylor College of Medicine
The Kidney Institute
Houston, Texas
Keith Superdock,
MD, FACP
Lankenau Hospital
Wynnewood, Pennsylvania
Garry Tobin, MD
Washington University
Clinical Associates Grant Medical Clinic
St. Louis, Missouri
Stephen Tomlanovich,
MD
University of California, San Francisco School of Medicine
San Francisco, California
Alan Wilkinson,
MD, FRCP
University of California, Los Angeles
David Geffen School of Medicine
Los Angeles, California
|
| DISCLOSURE: |
|
In accordance
with the Accreditation Council for Continuing Medical Education
Standards for Commercial Support, the faculty make the
following disclosures:
Douglas
Amare, MD
Honoraria: Fujisawa Healthcare, Inc.
Mary
T. Behrens, MD, FACP
Honoraria: Fujisawa Healthcare, Inc.
Mark
Benfield, MD
Grants/Research Support: National Institutes of Health; Wyeth.
Margaret
Johnson Bia, MD
Honoraria: Fujisawa Healthcare, Inc.
Daniel
C. Brennan, MD, FACP
Grants/Research Support:: Fujisawa Healthcare, Inc; Genzyme;
Novartis; Roche.
Honoraria: Fujisawa Healthcare, Inc; Genzyme; Novartis; Roche.
Joseph
Buell, MD
None
David
C. Cronin II, MD, PhD
Honoraria: Fujisawa Healthcare, Inc.
Gabriel
Danovitch, MD
Grants/Research Support:: Fujisawa Healthcare, Inc; Roche;
Wyeth.
Honoraria: Fujisawa Healthcare, Inc; Roche; Novartis.
Robert
Gaston, MD
Grants/Research Support:: Fujisawa Healthcare, Inc; Genentech;
Pfizer; Roche.
Consultant: Fujisawa Healthcare, Inc; Novartis.
Honoraria: Fujisawa Healthcare, Inc; Genzyme; Roche.
Andrew
D. Howard, MD, FACP
Consultant: Fujisawa Healthcare, Inc.
Honoraria: Fujisawa Healthcare, Inc.
Stanley
Jordan, MD
Grants/Research Support:: Bayer; National Institutes of Health.
Consultant: Pfizer.
Honoraria: Fujisawa Healthcare, Inc.
Michelle
Josephson, MD
Honoraria: Fujisawa Healthcare, Inc.
Steve
Katznelson, MD
None
David
Laskow, MD
Grants/Research Support: Fujisawa Healthcare, Inc.
Honoraria: Fujisawa Healthcare, Inc.
Mariana
Markell, MD
Honoraria: Fujisawa Healthcare, Inc.
Jerry
McCauley, MD, MPH
Honoraria: Fujisawa Healthcare, Inc.
Minnie
Sarwal, MD, PhD
Honoraria: Fujisawa Healthcare, Inc.
Hamid
Shidban, MD
Consultant: Fujisawa Healthcare, Inc.
Honoraria: Fujisawa Healthcare, Inc.
Wadi
Suki, MD, FACP
Honoraria: Fujisawa Healthcare, Inc.
Keith
Superdock, MD, FACP
Honoraria: Fujisawa Healthcare, Inc.
Garry
Tobin, MD
Honoraria: Fujisawa Healthcare, Inc.
Stephen
Tomlanovich, MD
Grants/Research Support: Fujisawa Healthcare, Inc; Novartis;
Roche.
Honoraria: Fujisawa Healthcare, Inc; Novartis; Roche.
Alan
Wilkinson, MD, FRCP
Grants/Research Support: Fujisawa Healthcare, Inc; Genzyme;
Novartis; Roche.
Because of the nature of preliminary studies, some products
mentioned are unlabeled and investigational. Dosages, indications,
and methods of use of drugs mentioned in this publication
may reflect the experience of the authors, clinical literature,
or other resources. Therefore, please see the full prescribing
information before using any licensed product mentioned.
|
| GRANT
SUPPORT: |
| This
online course is supported through an unrestricted educational
grant from Astellas Pharma US, Inc. |
| CME
PARTICIPATION: |
| To participate
in this online course for CME credit, please review the objectives
before beginning the program. Complete the course and the
self-assessment test before July 31, 2010 to receive
CME credit. Your certificate will then be available online.
This
process should take approximately 2 hours. |
| ACCREDITATION: |
|
The University of Alabama School
of Medicine is accredited by the Accreditation Council
for Continuing Medical Education to provide continuing
medical education for physicians.
The University of Alabama School of Medicine designates this educational activity for a maximum of 2 AMA PRA Category 1 credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The boards of nursing in many
states, including Alabama, recognize Category 1 continuing
medical education courses as acceptable activities for
the renewal of license to practice nursing.
|
| Top of Page |
| Module
components : |
|
Each
module comprises of a PDF file containing current, easy-to-read
information with charts, graphics, tables, and references;
a slide presentation with slide note. Please read
the information and complete the self assessment test to
receive CME credit and a certificate.
Adobe
Acrobat Reader(Version 4.0 or above) is needed for
this course. Download the Free Adobe Acrobat Reader here!
|
 |
Booklet
content 
Slide
presentation
|
| Self-Assessment
Test: |
| To apply
for 2 Category 1 credits, complete the self-assessment
test and you should receive an online certificate immediately. |
| To
take the test click
here! |
|
